首页> 外文期刊>Journal of Surgical Oncology >Positive node‐ratio in curative‐intent treatment for gastric cancer is a strong independent prognostic factor for 5‐year overall survival
【24h】

Positive node‐ratio in curative‐intent treatment for gastric cancer is a strong independent prognostic factor for 5‐year overall survival

机译:胃癌治疗意图治疗的阳性节点比是5年整体存活的强烈独立预后因素

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Introduction This study addressed whether the positive node‐ratio (N‐ratio) for patients who underwent curative‐intent treatment was an independent prognostic factor of overall survival (OS) for gastric adenocarcinoma (GA). Methods Consecutive patients who underwent gastrectomy for GA with at least 15 harvested nodes were evaluated for 5‐year OS. The best threshold was determined using the area under an receiver operating characteristic (ROC) curve. Univariate and multivariate models were assessed looking for independent prognostic factors for OS. Results From 1994 to 2015, 398 consecutive patients were evaluated. The N‐ratio ≥11% had an accuracy of 0.764, the sensitivity of 71.1%, the specificity of 81.7%, positive predictive value (PPV) of 91.7%, and odds ratio (OR) of 11. After multivariate analysis for OS, age ≥70 years (HR 1.44), need for total gastrectomy (HR 1.45), need for extended resection (HR 1.7), and N‐ratio ≥11% (HR 3.7) were unfavorable prognostic factors. D2 lymphadenectomy (HR 0.53) was a protective factor. The median OS according to N‐ratio was 14 months for N‐ratio 11 vs 58 months for N‐ratio 11%. Conclusion The N‐ratio ≥11% was an independent negative prognostic factor for patients who underwent treatment for GA with curative intent. The N‐ratio ≥11% presented high specificity, high PPV and high OR for risk of death for 5 years after surgery.
机译:摘要介绍该研究解决了接受疗效治疗的患者的阳性节点比(n-比率)是胃腺癌(GA)的整体存活(OS)的独立预后因子。方法评价5年的OS对遗传术接受胃切除术的胃切除术的患者。使用接收器操作特性(ROC)曲线下的区域确定最佳阈值。评估单变量和多变量模型寻找OS的独立预后因素。结果1994年至2015年,共同评估了398名患者。 N比≥11%的精度为0.764,灵敏度为71.1%,特异性为81.7%,阳性预测值(PPV)为91.7%,差异比(或)为11.多变量分析OS后,年龄≥70岁(HR 1.44),需要总胃切除术(HR 1.45),需要扩展切除(HR 1.7),N-比率≥11%(HR 3.7)是不利的预后因素。 D2淋巴结切除术(HR 0.53)是一种保护剂。对于N比的N比的中位OS为N比,N比率为14个月,N-比率为158个月。结论N比≥11%是对治疗治疗意图治疗的患者的独立负预后因素。 N比≥11%呈现出高特异性,高PPV和高或用于手术后5年的死亡风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号